| Literature DB >> 15580533 |
R Thomasius1, E Gouzoulis-Mayfrank, C Karus, H Wiedenmann, L Hermle, P M Sack, D Zeichner, U Küstner, A Schindler, A Krüger, S Uhlmann, K U Petersen, P Zapletalova, L Wartberg, C G Schütz, M Schulte-Markwort, J Obrocki, A Heinz, A Schmoldt.
Abstract
Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15580533 DOI： 10.1055/s-2004-818531
Source DB: PubMed Journal: Fortschr Neurol Psychiatr ISSN： 0720-4299 Impact factor: 0.752